GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Sona Nanotech Inc (OTCPK:SNANF) » Definitions » Operating Margin %

SNANF (Sona Nanotech) Operating Margin % : 0.00% (As of Jan. 2025)


View and export this data going back to 2006. Start your Free Trial

What is Sona Nanotech Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Sona Nanotech's Operating Income for the three months ended in Jan. 2025 was $-0.62 Mil. Sona Nanotech's Revenue for the three months ended in Jan. 2025 was $0.00 Mil. Therefore, Sona Nanotech's Operating Margin % for the quarter that ended in Jan. 2025 was 0.00%.

The historical rank and industry rank for Sona Nanotech's Operating Margin % or its related term are showing as below:


SNANF's Operating Margin % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: -1.28
* Ranked among companies with meaningful Operating Margin % only.

Sona Nanotech's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Sona Nanotech's Operating Income for the three months ended in Jan. 2025 was $-0.62 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jan. 2025 was $-2.21 Mil.


Sona Nanotech Operating Margin % Historical Data

The historical data trend for Sona Nanotech's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sona Nanotech Operating Margin % Chart

Sona Nanotech Annual Data
Trend Oct14 Oct15 Oct16 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sona Nanotech Quarterly Data
Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sona Nanotech's Operating Margin %

For the Diagnostics & Research subindustry, Sona Nanotech's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sona Nanotech's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Sona Nanotech's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Sona Nanotech's Operating Margin % falls into.


;
;

Sona Nanotech Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Sona Nanotech's Operating Margin % for the fiscal year that ended in Oct. 2024 is calculated as

Operating Margin %=Operating Income (A: Oct. 2024 ) / Revenue (A: Oct. 2024 )
=-2.124 / 0
= %

Sona Nanotech's Operating Margin % for the quarter that ended in Jan. 2025 is calculated as

Operating Margin %=Operating Income (Q: Jan. 2025 ) / Revenue (Q: Jan. 2025 )
=-0.619 / 0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sona Nanotech  (OTCPK:SNANF) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Sona Nanotech Operating Margin % Related Terms

Thank you for viewing the detailed overview of Sona Nanotech's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sona Nanotech Business Description

Traded in Other Exchanges
Address
1969 Upper Water Street, Suite 2001, Purdy’s Wharf Tower II, Halifax, NS, CAN, B3J 3R7
Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and various biomedical applications. The company's product includes Gemini and Saliva tests.

Sona Nanotech Headlines

From GuruFocus